Salute e Benessere
Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers
Oblique Therapeutics is a biotechnology company that focuses on developing new therapeutic methods for treating severe illnesses, especially in the area of pain management and also for other conditions. The company uses pioneering technology and innovative research methods to discover and develop new drug candidates.
KTH is the biggest technical university in Sweden and is one of Europe's leading technical institutions. The university is known for its research and education in technology and science, and its advanced research infrastructure, including the supercomputer, supports a broad range of scientific disciplines. The supercomputer in question is one of the most green computers in the world thanks to its energy-efficient architecture and due to using renewable electricity and recycling heat.
" " says the leading researcher in the project, Dr. Anna Reymer , from Oblique Therapeutics. " "
" says Patrick Norman , PDC's director
For additional information, pls contact: Anna Reymer (Anna.Reymer@obliquet.com), Olof Larsson (olof.larsson@obliquet.com) & Michaela Barth (caela@kth.se).
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/oblique-therapeutics-ab/r/oblique-therapeutics-and-the-kth-royal-institute-of-technology--kth--have-entered-into-a-strategic-c,c4003211
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/oblique-therapeutics-and-the-kth-royal-institute-of-technology-kth-have-entered-into-a-strategic-collaboration-to-analyse-protein-structures-using-supercomputers-302175679.html